Cargando…
Effect of arsenic trioxide on the Tregs ratio and the levels of IFN-γ, IL-4, IL-17 and TGF-β1 in the peripheral blood of severe aplastic anemia patients
Previous studies have suggested that the anticancer agent, arsenic trioxide (ATO), could attenuate T cell mediated immunity by not only inhibiting the proliferative response of T cells but by also increasing the frequency of regulatory T cells (Tregs). Furthermore, ATO represents a reasonable salvag...
Autores principales: | Zhao, Juanjuan, Song, Yongping, Liu, Lina, Yang, Shiwei, Fang, Baijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329005/ https://www.ncbi.nlm.nih.gov/pubmed/32590737 http://dx.doi.org/10.1097/MD.0000000000020630 |
Ejemplares similares
-
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
por: Li, Ning, et al.
Publicado: (2012) -
Human leukocyte antigen-DRB1 gene polymorphism and aplastic anemia: A meta-analysis
por: Liang, Lijie, et al.
Publicado: (2023) -
Successful sirolimus therapy of an aplastic anemia patient with chronic kidney disease: A case report
por: Niu, Haiyue, et al.
Publicado: (2020) -
De-escalation empirical antibiotic therapy improved survival for patients with severe aplastic anemia treated with antithymocyte globulin
por: Fu, Rong, et al.
Publicado: (2017) -
Aplastic anemia from past to the present: A bibliometric analysis with research trends and global productivity during 1980 to 2022
por: Bulduk, Tuba
Publicado: (2023)